Vimarsana
Biggest News Aggregation in the World

Page 30 - Seth Lederman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Seth Lederman Today - Breaking & Trending Today

Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025 - Vimarsana News

Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025

Share this article Share this article PALM BEACH, Fla., April 23, 2021 /PRNewswire/ -- Sleep is an essential need of all species… including homo sapiens, especially now during the pandemic. Sleep disorders are affecting a large pool of population, which has boosted the awareness about these disorders and other related ailments. Increase in the prevalence of sleep disorders has led to an expansion of private care centers and hospitals. These sleep centers have increased awareness among people about the importance of tracking sleep patterns for better sleep. This is driving the usage of hom...

Tonix hopes for COVID-19 drug tonic as it pens OyaGen antiviral pact - Vimarsana News

Tonix hopes for COVID-19 drug tonic as it pens OyaGen antiviral pact

(Volker Lannert/University of Bonn) Tonix Pharmaceuticals is opening an early-stage antiviral asset deal with OyaGen as the pair targets COVID-19. The research and license pact, financials of which were not made public, focuses on the antiviral inhibitor of SARS-CoV-2, TNX-3500 (aka sangivamycin, formerly OYA1), which Tonix believes can hit back against the pandemic virus and “potentially other viral disorders.”  The active ingredient of the drug has, in fact, been studied for safety in humans in prior research on cancer patients at the U.S. National Cancer Institute. New York-...

New to The Street - NEWSMAX Sunday April 17th 10AM EST Line Up Features Tonix Pharmaceuticals with CEO Seth Lederman, NativeCoin with President Randy Williams, Finxflo with CEO James Gillingham and More - Vimarsana News

New to The Street - NEWSMAX Sunday April 17th 10AM EST Line Up Features Tonix Pharmaceuticals with CEO Seth Lederman, NativeCoin with President Randy Williams, Finxflo with CEO James Gillingham and More

Share: NEW YORK, NY / ACCESSWIRE / April 17, 2021 / New To The Street will broadcast Show 168 this Sunday at 10 AM EST on NEWSMAX T.V. The show will feature Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, a research-driven biotechnology company. Dr. Seth talks about their pipeline of drugs in development - the Rally Study for Fibromyalgia confirmatory phase 3 study, their recent 10K, their recent raise of 110M gross funds raised in 2021, and the TNX 1800 Covid vaccine. NativeCoin (N8V) is launching its token to serve the over 560 NATIVE AMERICAN INDIAN TRI...

FMW Media Works Corp: New to The Street - NEWSMAX Sunday April 17th 10AM EST Line Up Features Tonix Pharmaceuticals with CEO Seth Lederman, NativeCoin with President Randy Williams, Finxflo with CEO James Gillingham and More - Vimarsana News

FMW Media Works Corp: New to The Street - NEWSMAX Sunday April 17th 10AM EST Line Up Features Tonix Pharmaceuticals with CEO Seth Lederman, NativeCoin with President Randy Williams, Finxflo with CEO James Gillingham and More

(0) NEW YORK, NY / ACCESSWIRE / April 17, 2021 / New To The Street will broadcast Show 168 this Sunday at 10 AM EST on NEWSMAX T.V. The show will feature Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, a research-driven biotechnology company. Dr. Seth talks about their pipeline of drugs in development - the Rally Study for Fibromyalgia confirmatory phase 3 study, their recent 10K, their recent raise of 110M gross funds raised in 2021, and the TNX 1800 Covid vaccine. NativeCoin (N8V) is launching its token to serve the over 560 NATIVE AMERICAN INDIAN TRIBES...

Emerging Growth Conference 3 Announced for March 17 - Vimarsana News

Emerging Growth Conference 3 Announced for March 17

Niche Companies in Tech, Pharma, Cannabis, Solar and more in Attendance